Back to companies

Ginkgo BioWorks Inc (Ginkgo BioWorks) a subsidiary of Ginkgo Bioworks Holdings, Inc. is a biotechnology company which offers automated organism engineering, enzyme discovery and cultured fragrances. The company also offers antibiotics, specialty chemicals, cannabinoids and others. It produces ingredients through fermentation with engineered yeasts for foods, perfumes, cosmetics markets; discover new enzymes used in applications including cheesemaking, pharmaceuticals, and stonewashed jeans. Ginkgo BioWorks also uses laboratory automation synthesis, software and automation, and high performance analytical tools to produce these products. The company build's foundries to scale the process of organism engineering using software and hardware automation tools. It partners with leading bio-industrial fermentation companies such as Ajinomoto and Cargill to improve the efficiency of the microbial strains. Ginkgo BioWorks is headquartered in Boston, Massachusetts, the US.

Gain a 360-degree view of Ginkgo BioWorks Inc and make more informed decisions for your business Gain a 360-degree view of Ginkgo BioWorks Inc and make more informed decisions for your business Contact Us
Headquarters United States of America

Address 27 Drydock Avenue, 8th Floor, Boston, Massachusetts, 02210


Telephone 1 877 4225362

Industry Pharmaceuticals and Healthcare

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Ginkgo BioWorks Inc premium industry data and analytics

20+

Pipeline Drugs

Identify which of Ginkgo BioWorks Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Ginkgo BioWorks Inc’s relevant decision makers and contact details.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Ginkgo BioWorks Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services
Specialty Chemicals Research and Development Service
Enzymes
Cannabinoids
XYZ
XYZ
XYZ
Understand Ginkgo BioWorks Inc portfolio and identify potential areas for collaboration Understand Ginkgo BioWorks Inc portfolio and identify potential areas for collaboration Contact Us

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Asset Purchase In April, the company announced the acquisition of AgBiome's platform assets.
2024 Acquisitions/Mergers/Takeovers In February, the company acquired Patch Biosciences.
2024 Asset Purchase In February, the company acquired the key assets of Reverie Labs.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Contact Us
Image for loader

Competitor Comparison

Key Parameters Ginkgo BioWorks Inc Sterogene Bioseparations Inc ZeptoMetrix LLC Microbiologics Inc
Headquarters United States of America United States of America United States of America United States of America
City Boston Carlsbad Buffalo St. Cloud
State/Province Massachusetts California New York Minnesota
No. of Employees - - - 200
Entity Type Private Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Executives
Name Position Board Since Age
Marijn Dekkers Chairman Executive Board - -
Jason Kelly Director; Chief Executive Officer; Founder Executive Board - -
Reshma Shetty Chief Operating Officer; Founder; Director; President Executive Board - -
Mark Dmytruk Chief Financial Officer Senior Management - -
Barry Canton Chief Technology Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Ginkgo BioWorks Inc key executives to enhance your sales strategy Gain insight into Ginkgo BioWorks Inc key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward